Ventric Health, based in Pasadena, California, has just launched a revamped website for the Vivio® System, which is a groundbreaking device for detecting heart failure. This non-invasive device is the only one cleared by the FDA to measure left ventricular end-diastolic pressure (LVEDP) in outpatient settings. The updated site aims to bridge the gap in heart failure diagnoses and offers valuable resources for doctors and healthcare systems.
Heart failure is often diagnosed too late. In fact, around 65% of patients only find out they have it in emergency rooms or hospitals, typically about 30 months after they first notice symptoms. This late diagnosis can lead to hefty costs. Managing late-stage heart failure can skyrocket to about $21,800 per patient each year, while early detection can reduce that to just $4,300. The aim is clear: detecting heart failure earlier can improve survival rates and quality of life for patients.
The website includes new features, such as:
- A comprehensive Resources Hub offering peer-reviewed research and guides tailored for both clinical and administrative leaders.
- A clear breakdown of heart failure progression, which helps in understanding the disease stages.
- A streamlined process for requesting demo sessions that outline what users can expect.
- In-depth content on the Vivio System and its real-world applications, along with an extensive FAQ section.
Dr. Thomas Cheek, Chief Medical Officer at Ventric Health, emphasizes that this site redesign reflects their ongoing commitment to provide healthcare systems with the crucial information needed for early heart failure detection.
The Vivio System uses a unique method to measure LVEDP: it analyzes cardiac pressure and volume waveforms in under five minutes, without invasive procedures. This quick turnaround can aid doctors in making informed decisions right at the point of care.
Recent studies affirm the system’s effectiveness. For example, a 2025 multicenter JAHA validation study highlights its reliability in early detection, while a 2025 HFSA abstract discusses its potential for pre-symptomatic Stage A detection.
Ventric Health is dedicated to enhancing heart failure detection and management. As healthcare continues to evolve, tools like the Vivio System play a crucial role in improving patient outcomes. With better awareness and earlier diagnosis, there’s hope for more effective treatment and better lives for those affected by heart failure.
To learn more about heart failure detection and the Vivio System, visit Ventric Health’s website.
Source link
heart failure, primary care physicians, LVEDP, primary care
